ID   CP2D6_HUMAN             Reviewed;         497 AA.
AC   P10635; Q16752; Q2XND6; Q2XND7; Q2XNE0; Q6B012; Q6NXU8;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 2.
DT   10-MAY-2017, entry version 190.
DE   RecName: Full=Cytochrome P450 2D6;
DE            EC=1.14.14.1 {ECO:0000269|PubMed:21576599};
DE   AltName: Full=CYPIID6;
DE   AltName: Full=Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};
DE   AltName: Full=Cytochrome P450-DB1;
DE   AltName: Full=Debrisoquine 4-hydroxylase;
GN   Name=CYP2D6; Synonyms=CYP2DL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3410476; DOI=10.1016/0888-7543(88)90100-0;
RA   Gonzalez F.J., Vilbois F., Hardwick J.P., McBride O.W., Nebert D.W.,
RA   Gelboin H.V., Meyer U.A.;
RT   "Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino
RT   acid sequence and assignment of the CYP2D locus to chromosome 22.";
RL   Genomics 2:174-179(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=3123997; DOI=10.1038/331442a0;
RA   Gonzalez F.J., Skoda R.C., Kimura S., Umeno M., Zanger U.M.,
RA   Nebert D.W., Gelboin H.V., Hardwick J.P., Meyer U.A.;
RT   "Characterization of the common genetic defect in humans deficient in
RT   debrisoquine metabolism.";
RL   Nature 331:442-446(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2574001;
RA   Kimura S., Umeno M., Skoda R.C., Meyer U.A., Gonzalez F.J.;
RT   "The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and
RT   identification of the polymorphic CYP2D6 gene, a related gene, and a
RT   pseudogene.";
RL   Am. J. Hum. Genet. 45:889-904(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE CYP2D6*1), IDENTIFICATION OF
RP   ALLELES CYP2D6*41B; CYP2D6*45A; CYP2D6*45B AND CYP2D6*46, VARIANTS
RP   HIS-26; LYS-155; CYS-296 AND THR-486, AND CHARACTERIZATION OF ISOZYMES
RP   CYP2D6.45 AND CYP2D6.46.
RX   PubMed=15768052; DOI=10.1038/sj.tpj.6500305;
RA   Gaedigk A., Bhathena A., Ndjountche L., Pearce R.E.,
RA   Abdel-Rahman S.M., Alander S.W., Bradford L.D., Rogan P.K.,
RA   Leeder J.S.;
RT   "Identification and characterization of novel sequence variations in
RT   the cytochrome P4502D6 (CYP2D6) gene in African Americans.";
RL   Pharmacogenomics J. 5:173-182(2005).
RN   [5]
RP   ERRATUM.
RA   Gaedigk A., Bhathena A., Ndjountche L., Pearce R.E.,
RA   Abdel-Rahman S.M., Alander S.W., Bradford L.D., Rogan P.K.,
RA   Leeder J.S.;
RL   Pharmacogenomics J. 5:276-276(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-26.
RA   Koch W.H., Nikoloff D.M., Lu W., Pan R.M., deLeon J., Wedlund P.J.;
RT   "CYP2D6 evolution and allele diversity among human races.";
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS CYS-296
RP   AND THR-486.
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS CYS-296 AND THR-486.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=21576599; DOI=10.1194/jlr.M014084;
RA   Honda A., Miyazaki T., Ikegami T., Iwamoto J., Maeda T., Hirayama T.,
RA   Saito Y., Teramoto T., Matsuzaki Y.;
RT   "Cholesterol 25-hydroxylation activity of CYP3A.";
RL   J. Lipid Res. 52:1509-1516(2011).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 34-497 IN COMPLEX WITH HEME,
RP   AND FUNCTION.
RX   PubMed=16352597; DOI=10.1074/jbc.M511232200;
RA   Rowland P., Blaney F.E., Smyth M.G., Jones J.J., Leydon V.R.,
RA   Oxbrow A.K., Lewis C.J., Tennant M.G., Modi S., Eggleston D.S.,
RA   Chenery R.J., Bridges A.M.;
RT   "Crystal structure of human cytochrome P450 2D6.";
RL   J. Biol. Chem. 281:7614-7622(2006).
RN   [11]
RP   VARIANT CYP2D6*9 LYS-281 DEL.
RX   PubMed=1844820;
RA   Tyndale R., Aoyama T., Broly F., Matsunaga T., Inaba T., Kalow W.,
RA   Gelboin H.V., Meyer U.A., Gonzalez F.J.;
RT   "Identification of a new variant CYP2D6 allele lacking the codon
RT   encoding Lys-281: possible association with the poor metabolizer
RT   phenotype.";
RL   Pharmacogenetics 1:26-32(1991).
RN   [12]
RP   VARIANTS CYP2D6*10 SER-34 AND THR-486.
RX   PubMed=8287064;
RA   Yokota H., Tamura S., Furuya H., Kimura S., Watanabe M., Kanazawa I.,
RA   Kondo I., Gonzalez F.J.;
RT   "Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese
RT   population associated with lower in vivo rates of sparteine
RT   metabolism.";
RL   Pharmacogenetics 3:256-263(1993).
RN   [13]
RP   VARIANT CYP2D6*7 PRO-324.
RX   PubMed=7845481; DOI=10.1007/BF00178963;
RA   Evert B., Griese E.U., Eichelbaum M.;
RT   "A missense mutation in exon 6 of the CYP2D6 gene leading to a
RT   histidine 324 to proline exchange is associated with the poor
RT   metabolizer phenotype of sparteine.";
RL   Naunyn Schmiedebergs Arch. Pharmacol. 350:434-439(1994).
RN   [14]
RP   VARIANT CYP2D6*6B/6C GLU-212.
RX   PubMed=7868129; DOI=10.1007/BF00225204;
RA   Daly A.K., Leathart J.B., London S.J., Idle J.R.;
RT   "An inactive cytochrome P450 CYP2D6 allele containing a deletion and a
RT   base substitution.";
RL   Hum. Genet. 95:337-341(1995).
RN   [15]
RP   VARIANT CYP2D6*17 ILE-107.
RX   PubMed=8971426; DOI=10.1046/j.1365-2125.1996.00489.x;
RA   Masimirembwa C., Persson I., Bertilsson L., Hasler J.,
RA   Ingelman-Sundberg M.;
RT   "A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a
RT   black African population: association with diminished debrisoquine
RT   hydroxylase activity.";
RL   Br. J. Clin. Pharmacol. 42:713-719(1996).
RN   [16]
RP   VARIANT CYP2D6*12 ARG-42.
RX   PubMed=8655150; DOI=10.1007/BF02281880;
RA   Marez D., Legrand M., Sabbagh N., Lo-Guidice J.-M., Boone P.,
RA   Broly F.;
RT   "An additional allelic variant of the CYP2D6 gene causing impaired
RT   metabolism of sparteine.";
RL   Hum. Genet. 97:668-670(1996).
RN   [17]
RP   VARIANTS.
RX   PubMed=9241659;
RA   Marez D., Legrand M., Sabbagh N., Guidice J.M., Spire C.,
RA   Lafitte J.J., Meyer U.A., Broly F.;
RT   "Polymorphism of the cytochrome P450 CYP2D6 gene in a European
RT   population: characterization of 48 mutations and 53 alleles, their
RT   frequencies and evolution.";
RL   Pharmacogenetics 7:193-202(1997).
RN   [18]
RP   VARIANT CYP2D6*14 ARG-169.
RX   PubMed=10064570;
RA   Wang S.L., Lai M.D., Huang J.D.;
RT   "G169R mutation diminishes the metabolic activity of CYP2D6 in
RT   Chinese.";
RL   Drug Metab. Dispos. 27:385-388(1999).
RN   [19]
RP   VARIANTS MET-11; HIS-26; SER-34; MET-91; ARG-94; ILE-107; ILE-120;
RP   LYS-155; SER-237; CYS-296; LYS-418; ALA-469; TYR-478 AND THR-486.
RX   PubMed=15469410; DOI=10.1517/14622416.5.7.895;
RA   Solus J.F., Arietta B.J., Harris J.R., Sexton D.P., Steward J.Q.,
RA   McMunn C., Ihrie P., Mehall J.M., Edwards T.L., Dawson E.P.;
RT   "Genetic variation in eleven phase I drug metabolism genes in an
RT   ethnically diverse population.";
RL   Pharmacogenomics 5:895-931(2004).
RN   [20]
RP   VARIANTS CYP2D6*87 VAL-5; GLN-25; CYP2D6*10 SER-34; CYP2D6*88 ALA-104;
RP   CYP2D6*89 SER-142; CYP2D6*90 ARG-147; CYP2D6*91 SER-161; LEU-164;
RP   LYS-215; SER-219; CYP2D6*93 PRO-249; CYP2D6*2 CYS-296; MET-327;
RP   ASN-336; CYP2D6*94 GLY-337; MET-342; GLN-344; CYS-440; CYP2D6*97
RP   LEU-457; CYP2D6*98 ASP-463; CYP2D6*10/2 THR-486 AND CYS-497.
RX   PubMed=25469868; DOI=10.1111/bcpt.12363;
RA   Dai D.P., Geng P.W., Wang S.H., Cai J., Hu L.M., Nie J.J., Hu J.H.,
RA   Hu G.X., Cai J.P.;
RT   "In vitro functional assessment of 22 newly identified CYP2D6 allelic
RT   variants in the Chinese population.";
RL   Basic Clin. Pharmacol. Toxicol. 117:39-43(2015).
CC   -!- FUNCTION: Responsible for the metabolism of many drugs and
CC       environmental chemicals that it oxidizes. It is involved in the
CC       metabolism of drugs such as antiarrhythmics, adrenoceptor
CC       antagonists, and tricyclic antidepressants.
CC       {ECO:0000269|PubMed:16352597}.
CC   -!- CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] +
CC       O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.
CC       {ECO:0000269|PubMed:21576599}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane
CC       {ECO:0000269|PubMed:21576599}; Peripheral membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P10635-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P10635-2; Sequence=VSP_044486;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: By pregnancy.
CC   -!- POLYMORPHISM: Genetic variations in CYP2D6 are the cause of poor
CC       drug metabolism CYP2D6-related [MIM:608902]. The CYP2D6 gene is
CC       highly polymorphic. CYP2D6 activity ranges widely within a
CC       population comprising ultrarapid (UM), extensive (EM),
CC       intermediate (IM) and poor (PM) metabolizer phenotypes. UM and PM
CC       are those most at risk for treatment failure or dose-dependent
CC       drug toxicity, respectively. Of the Caucasian populations of
CC       Europe and North America, 5%-10% are of the PM phenotype and are
CC       unable to metabolize the antihypersensitive drug debrisoquine and
CC       numerous other drugs. Different alleles are known, including
CC       CYP2D6*1 (PubMed:15768052), CYP2D6*2 (PubMed:25469868),
CC       CYP2D6*6B/6C (PubMed:7868129), CYP2D6*7 also known CYP2D6E
CC       (PubMed:7845481), CYP2D6*9 also known CYP2D6C (PubMed:1844820),
CC       CYP2D6*10 also known CYP2D6J (PubMed:8287064, PubMed:25469868),
CC       CYP2D6*12 (PubMed:8655150), CYP2D6*14 (PubMed:10064570), CYP2D6*17
CC       also known CYP2D6Z (PubMed:8971426), CYP2D6*41B (PubMed:15768052),
CC       CYP2D6*45A (PubMed:15768052), CYP2D6*45B (PubMed:15768052),
CC       CYP2D6*46 (PubMed:15768052), CYP2D6*87 (PubMed:25469868),
CC       CYP2D6*88 (PubMed:25469868), CYP2D6*89 (PubMed:25469868),
CC       CYP2D6*90 (PubMed:25469868), CYP2D6*91 (PubMed:25469868),
CC       CYP2D6*93 (PubMed:25469868), C CYP2D6*94 (PubMed:25469868),
CC       CYP2D6*97 (PubMed:25469868) and CYP2D6*98 (PubMed:25469868).
CC       Isozymes CYP2D6.45 (Lys-155, Cys-296 and Thr-486) and CYP2D6.46
CC       (His-26, Lys-155, Cys-296 and Thr-486) are functional
CC       (PubMed:15768052). {ECO:0000269|PubMed:10064570,
CC       ECO:0000269|PubMed:15768052, ECO:0000269|PubMed:16352597,
CC       ECO:0000269|PubMed:1844820, ECO:0000269|PubMed:25469868,
CC       ECO:0000269|PubMed:7845481, ECO:0000269|PubMed:7868129,
CC       ECO:0000269|PubMed:8655150, ECO:0000269|PubMed:8971426}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP2D6 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp2d6.htm";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CYP2D6 entry;
CC       URL="https://en.wikipedia.org/wiki/CYP2D6";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M20403; AAA52153.1; -; mRNA.
DR   EMBL; X08006; CAA30807.1; -; mRNA.
DR   EMBL; M33388; AAA53500.1; -; Genomic_DNA.
DR   EMBL; AY545216; AAS55001.1; -; Genomic_DNA.
DR   EMBL; DQ282144; ABB77895.1; -; Genomic_DNA.
DR   EMBL; DQ282145; ABB77896.1; -; Genomic_DNA.
DR   EMBL; DQ282146; ABB77897.1; -; Genomic_DNA.
DR   EMBL; DQ282151; ABB77899.1; -; Genomic_DNA.
DR   EMBL; DQ282154; ABB77902.1; -; Genomic_DNA.
DR   EMBL; DQ282155; ABB77903.1; -; Genomic_DNA.
DR   EMBL; BX247885; CAP58857.1; -; Genomic_DNA.
DR   EMBL; BC066877; AAH66877.1; -; mRNA.
DR   EMBL; BC075023; AAH75023.1; -; mRNA.
DR   EMBL; BC075024; AAH75024.1; -; mRNA.
DR   CCDS; CCDS33657.1; -. [P10635-2]
DR   CCDS; CCDS46721.1; -. [P10635-1]
DR   PIR; S01199; O4HUD1.
DR   RefSeq; NP_000097.3; NM_000106.5. [P10635-1]
DR   RefSeq; NP_001020332.2; NM_001025161.2. [P10635-2]
DR   UniGene; Hs.648256; -.
DR   PDB; 2F9Q; X-ray; 3.00 A; A/B/C/D=34-497.
DR   PDB; 3QM4; X-ray; 2.85 A; A/B=34-497.
DR   PDB; 3TBG; X-ray; 2.10 A; A/B/C/D=34-497.
DR   PDB; 3TDA; X-ray; 2.67 A; A/B/C/D=34-497.
DR   PDB; 4WNT; X-ray; 2.60 A; A/B=34-497.
DR   PDB; 4WNU; X-ray; 2.26 A; A/B/C/D=34-497.
DR   PDB; 4WNV; X-ray; 2.35 A; A/B/C/D=48-497.
DR   PDB; 4WNW; X-ray; 3.30 A; A/B=34-497.
DR   PDB; 4XRY; X-ray; 2.50 A; A/B/C/D=34-497.
DR   PDB; 4XRZ; X-ray; 2.40 A; A/B/C/D=34-497.
DR   PDB; 5TFT; X-ray; 2.71 A; A/B/C/D=34-497.
DR   PDB; 5TFU; X-ray; 2.75 A; A/B/C/D=34-497.
DR   PDBsum; 2F9Q; -.
DR   PDBsum; 3QM4; -.
DR   PDBsum; 3TBG; -.
DR   PDBsum; 3TDA; -.
DR   PDBsum; 4WNT; -.
DR   PDBsum; 4WNU; -.
DR   PDBsum; 4WNV; -.
DR   PDBsum; 4WNW; -.
DR   PDBsum; 4XRY; -.
DR   PDBsum; 4XRZ; -.
DR   PDBsum; 5TFT; -.
DR   PDBsum; 5TFU; -.
DR   ProteinModelPortal; P10635; -.
DR   SMR; P10635; -.
DR   BioGrid; 107940; 4.
DR   STRING; 9606.ENSP00000353820; -.
DR   BindingDB; P10635; -.
DR   ChEMBL; CHEMBL289; -.
DR   DrugBank; DB01562; 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine.
DR   DrugBank; DB01472; 4-Methoxyamphetamine.
DR   DrugBank; DB05812; Abiraterone.
DR   DrugBank; DB01193; Acebutolol.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB03128; Acetylcholine.
DR   DrugBank; DB01426; Ajmaline.
DR   DrugBank; DB00918; Almotriptan.
DR   DrugBank; DB06203; Alogliptin.
DR   DrugBank; DB00866; Alprenolol.
DR   DrugBank; DB01424; Aminophenazone.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00381; Amlodipine.
DR   DrugBank; DB00613; Amodiaquine.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB00182; Amphetamine.
DR   DrugBank; DB00701; Amprenavir.
DR   DrugBank; DB00276; Amsacrine.
DR   DrugBank; DB01435; Antipyrine.
DR   DrugBank; DB01429; Aprindine.
DR   DrugBank; DB01274; Arformoterol.
DR   DrugBank; DB01238; Aripiprazole.
DR   DrugBank; DB06697; Artemether.
DR   DrugBank; DB06216; Asenapine.
DR   DrugBank; DB00637; Astemizole.
DR   DrugBank; DB00289; Atomoxetine.
DR   DrugBank; DB01076; Atorvastatin.
DR   DrugBank; DB00972; Azelastine.
DR   DrugBank; DB00245; Benzatropine.
DR   DrugBank; DB06770; Benzyl alcohol.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB00195; Betaxolol.
DR   DrugBank; DB01128; Bicalutamide.
DR   DrugBank; DB04889; Bicifadine.
DR   DrugBank; DB00810; Biperiden.
DR   DrugBank; DB00612; Bisoprolol.
DR   DrugBank; DB00188; Bortezomib.
DR   DrugBank; DB09128; Brexpiprazole.
DR   DrugBank; DB00835; Brompheniramine.
DR   DrugBank; DB06726; Bufuralol.
DR   DrugBank; DB00297; Bupivacaine.
DR   DrugBank; DB00921; Buprenorphine.
DR   DrugBank; DB01156; Bupropion.
DR   DrugBank; DB00490; Buspirone.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB01197; Captopril.
DR   DrugBank; DB00748; Carbinoxamine.
DR   DrugBank; DB06016; Cariprazine.
DR   DrugBank; DB00521; Carteolol.
DR   DrugBank; DB01136; Carvedilol.
DR   DrugBank; DB00482; Celecoxib.
DR   DrugBank; DB00567; Cephalexin.
DR   DrugBank; DB00439; Cerivastatin.
DR   DrugBank; DB00185; Cevimeline.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB00608; Chloroquine.
DR   DrugBank; DB01114; Chlorphenamine.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB00356; Chlorzoxazone.
DR   DrugBank; DB00169; Cholecalciferol.
DR   DrugBank; DB01410; Ciclesonide.
DR   DrugBank; DB01166; Cilostazol.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB01012; Cinacalcet.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB00215; Citalopram.
DR   DrugBank; DB00283; Clemastine.
DR   DrugBank; DB04920; Clevidipine.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01242; Clomipramine.
DR   DrugBank; DB00575; Clonidine.
DR   DrugBank; DB00257; Clotrimazole.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB09065; Cobicistat.
DR   DrugBank; DB00907; Cocaine.
DR   DrugBank; DB00318; Codeine.
DR   DrugBank; DB00924; Cyclobenzaprine.
DR   DrugBank; DB00531; Cyclophosphamide.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB06292; Dapagliflozin.
DR   DrugBank; DB00496; Darifenacin.
DR   DrugBank; DB09183; Dasabuvir.
DR   DrugBank; DB04840; Debrisoquin.
DR   DrugBank; DB00705; Delavirdine.
DR   DrugBank; DB01151; Desipramine.
DR   DrugBank; DB00967; Desloratadine.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB01191; Dexfenfluramine.
DR   DrugBank; DB00633; Dexmedetomidine.
DR   DrugBank; DB06701; Dexmethylphenidate.
DR   DrugBank; DB01576; Dextroamphetamine.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB00647; Dextropropoxyphene.
DR   DrugBank; DB01551; Dihydrocodeine.
DR   DrugBank; DB00343; Diltiazem.
DR   DrugBank; DB01093; Dimethyl sulfoxide.
DR   DrugBank; DB01075; Diphenhydramine.
DR   DrugBank; DB00757; Dolasetron.
DR   DrugBank; DB01184; Domperidone.
DR   DrugBank; DB00843; Donepezil.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB00590; Doxazosin.
DR   DrugBank; DB01142; Doxepin.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB00476; Duloxetine.
DR   DrugBank; DB00625; Efavirenz.
DR   DrugBank; DB00216; Eletriptan.
DR   DrugBank; DB09039; Eliglustat.
DR   DrugBank; DB01228; Encainide.
DR   DrugBank; DB06735; Enclomiphene.
DR   DrugBank; DB08899; Enzalutamide.
DR   DrugBank; DB00751; Epinastine.
DR   DrugBank; DB00530; Erlotinib.
DR   DrugBank; DB01175; Escitalopram.
DR   DrugBank; DB06678; Esmirtazapine.
DR   DrugBank; DB01466; Ethylmorphine.
DR   DrugBank; DB01628; Etoricoxib.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB00574; Fenfluramine.
DR   DrugBank; DB06702; Fesoterodine.
DR   DrugBank; DB00950; Fexofenadine.
DR   DrugBank; DB08868; Fingolimod.
DR   DrugBank; DB01195; Flecainide.
DR   DrugBank; DB04841; Flunarizine.
DR   DrugBank; DB00472; Fluoxetine.
DR   DrugBank; DB00623; Fluphenazine.
DR   DrugBank; DB01095; Fluvastatin.
DR   DrugBank; DB00176; Fluvoxamine.
DR   DrugBank; DB00983; Formoterol.
DR   DrugBank; DB00674; Galantamine.
DR   DrugBank; DB00317; Gefitinib.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00889; Granisetron.
DR   DrugBank; DB01218; Halofantrine.
DR   DrugBank; DB00502; Haloperidol.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00667; Histamine Phosphate.
DR   DrugBank; DB00956; Hydrocodone.
DR   DrugBank; DB00327; Hydromorphone.
DR   DrugBank; DB01611; Hydroxychloroquine.
DR   DrugBank; DB01005; Hydroxyurea.
DR   DrugBank; DB00557; Hydroxyzine.
DR   DrugBank; DB09053; Ibrutinib.
DR   DrugBank; DB01177; Idarubicin.
DR   DrugBank; DB04946; Iloperidone.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB00224; Indinavir.
DR   DrugBank; DB00332; Ipratropium bromide.
DR   DrugBank; DB01029; Irbesartan.
DR   DrugBank; DB00951; Isoniazid.
DR   DrugBank; DB01167; Itraconazole.
DR   DrugBank; DB09570; Ixazomib.
DR   DrugBank; DB01026; Ketoconazole.
DR   DrugBank; DB00598; Labetalol.
DR   DrugBank; DB00448; Lansoprazole.
DR   DrugBank; DB00528; Lercanidipine.
DR   DrugBank; DB01235; Levodopa.
DR   DrugBank; DB08918; Levomilnacipran.
DR   DrugBank; DB00281; Lidocaine.
DR   DrugBank; DB00589; Lisuride.
DR   DrugBank; DB01206; Lomustine.
DR   DrugBank; DB00836; Loperamide.
DR   DrugBank; DB01601; Lopinavir.
DR   DrugBank; DB00455; Loratadine.
DR   DrugBank; DB04871; Lorcaserin.
DR   DrugBank; DB00227; Lovastatin.
DR   DrugBank; DB06708; Lumefantrine.
DR   DrugBank; DB00934; Maprotiline.
DR   DrugBank; DB00358; Mefloquine.
DR   DrugBank; DB00532; Mephenytoin.
DR   DrugBank; DB06691; Mepyramine.
DR   DrugBank; DB01071; Mequitazine.
DR   DrugBank; DB00933; Mesoridazine.
DR   DrugBank; DB00333; Methadone.
DR   DrugBank; DB01577; Methamphetamine.
DR   DrugBank; DB00703; Methazolamide.
DR   DrugBank; DB00763; Methimazole.
DR   DrugBank; DB01403; Methotrimeprazine.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB06800; Methylnaltrexone.
DR   DrugBank; DB00422; Methylphenidate.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB01233; Metoclopramide.
DR   DrugBank; DB00264; Metoprolol.
DR   DrugBank; DB00379; Mexiletine.
DR   DrugBank; DB06148; Mianserin.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB00211; Midodrine.
DR   DrugBank; DB00834; Mifepristone.
DR   DrugBank; DB00805; Minaprine.
DR   DrugBank; DB08893; Mirabegron.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB01171; Moclobemide.
DR   DrugBank; DB00295; Morphine.
DR   DrugBank; DB09049; Naloxegol.
DR   DrugBank; DB00731; Nateglinide.
DR   DrugBank; DB04861; Nebivolol.
DR   DrugBank; DB01149; Nefazodone.
DR   DrugBank; DB00220; Nelfinavir.
DR   DrugBank; DB09048; Netupitant.
DR   DrugBank; DB00238; Nevirapine.
DR   DrugBank; DB00627; Niacin.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB00699; Nicergoline.
DR   DrugBank; DB02701; Nicotinamide.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB04868; Nilotinib.
DR   DrugBank; DB00336; Nitrofural.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00338; Omeprazole.
DR   DrugBank; DB00904; Ondansetron.
DR   DrugBank; DB01096; Oxamniquine.
DR   DrugBank; DB01580; Oxprenolol.
DR   DrugBank; DB01062; Oxybutynin.
DR   DrugBank; DB00497; Oxycodone.
DR   DrugBank; DB06412; Oxymetholone.
DR   DrugBank; DB01192; Oxymorphone.
DR   DrugBank; DB01267; Paliperidone.
DR   DrugBank; DB00377; Palonosetron.
DR   DrugBank; DB06603; Panobinostat.
DR   DrugBank; DB00715; Paroxetine.
DR   DrugBank; DB06589; Pazopanib.
DR   DrugBank; DB00738; Pentamidine.
DR   DrugBank; DB01186; Pergolide.
DR   DrugBank; DB01074; Perhexiline.
DR   DrugBank; DB00850; Perphenazine.
DR   DrugBank; DB00454; Pethidine.
DR   DrugBank; DB03783; Phenacetin.
DR   DrugBank; DB00914; Phenformin.
DR   DrugBank; DB00191; Phentermine.
DR   DrugBank; DB01100; Pimozide.
DR   DrugBank; DB00960; Pindolol.
DR   DrugBank; DB01132; Pioglitazone.
DR   DrugBank; DB00592; Piperazine.
DR   DrugBank; DB01621; Pipotiazine.
DR   DrugBank; DB08901; Ponatinib.
DR   DrugBank; DB00175; Pravastatin.
DR   DrugBank; DB01058; Praziquantel.
DR   DrugBank; DB01087; Primaquine.
DR   DrugBank; DB01035; Procainamide.
DR   DrugBank; DB00433; Prochlorperazine.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB01131; Proguanil.
DR   DrugBank; DB01069; Promethazine.
DR   DrugBank; DB01182; Propafenone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB00571; Propranolol.
DR   DrugBank; DB00344; Protriptyline.
DR   DrugBank; DB00852; Pseudoephedrine.
DR   DrugBank; DB00205; Pyrimethamine.
DR   DrugBank; DB01224; Quetiapine.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00468; Quinine.
DR   DrugBank; DB01129; Rabeprazole.
DR   DrugBank; DB00863; Ranitidine.
DR   DrugBank; DB00243; Ranolazine.
DR   DrugBank; DB00234; Reboxetine.
DR   DrugBank; DB00409; Remoxipride.
DR   DrugBank; DB01201; Rifapentine.
DR   DrugBank; DB00734; Risperidone.
DR   DrugBank; DB00503; Ritonavir.
DR   DrugBank; DB00989; Rivastigmine.
DR   DrugBank; DB09291; Rolapitant.
DR   DrugBank; DB00268; Ropinirole.
DR   DrugBank; DB00296; Ropivacaine.
DR   DrugBank; DB00412; Rosiglitazone.
DR   DrugBank; DB05271; Rotigotine.
DR   DrugBank; DB01698; Rutin.
DR   DrugBank; DB01232; Saquinavir.
DR   DrugBank; DB01037; Selegiline.
DR   DrugBank; DB06144; Sertindole.
DR   DrugBank; DB01104; Sertraline.
DR   DrugBank; DB00203; Sildenafil.
DR   DrugBank; DB00641; Simvastatin.
DR   DrugBank; DB00398; Sorafenib.
DR   DrugBank; DB06727; Sparteine.
DR   DrugBank; DB00259; Sulfanilamide.
DR   DrugBank; DB06729; Sulfaphenazole.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB00706; Tamsulosin.
DR   DrugBank; DB06204; Tapentadol.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB00976; Telithromycin.
DR   DrugBank; DB06287; Temsirolimus.
DR   DrugBank; DB00857; Terbinafine.
DR   DrugBank; DB00342; Terfenadine.
DR   DrugBank; DB04905; Tesmilifene.
DR   DrugBank; DB04844; Tetrabenazine.
DR   DrugBank; DB00277; Theophylline.
DR   DrugBank; DB00679; Thioridazine.
DR   DrugBank; DB01623; Thiothixene.
DR   DrugBank; DB00208; Ticlopidine.
DR   DrugBank; DB00373; Timolol.
DR   DrugBank; DB01409; Tiotropium.
DR   DrugBank; DB00932; Tipranavir.
DR   DrugBank; DB01036; Tolterodine.
DR   DrugBank; DB05109; Trabectedin.
DR   DrugBank; DB00193; Tramadol.
DR   DrugBank; DB00752; Tranylcypromine.
DR   DrugBank; DB00656; Trazodone.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugBank; DB00792; Tripelennamine.
DR   DrugBank; DB00427; Triprolidine.
DR   DrugBank; DB00209; Trospium.
DR   DrugBank; DB09076; Umeclidinium.
DR   DrugBank; DB08881; Vemurafenib.
DR   DrugBank; DB00285; Venlafaxine.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB06684; Vilazodone.
DR   DrugBank; DB00570; Vinblastine.
DR   DrugBank; DB00361; Vinorelbine.
DR   DrugBank; DB09068; Vortioxetine.
DR   DrugBank; DB01392; Yohimbine.
DR   DrugBank; DB00549; Zafirlukast.
DR   DrugBank; DB00943; Zalcitabine.
DR   DrugBank; DB00246; Ziprasidone.
DR   DrugBank; DB00425; Zolpidem.
DR   DrugBank; DB01624; Zuclopenthixol.
DR   GuidetoPHARMACOLOGY; 1329; -.
DR   SwissLipids; SLP:000001204; -.
DR   iPTMnet; P10635; -.
DR   PhosphoSitePlus; P10635; -.
DR   BioMuta; CYP2D6; -.
DR   DMDM; 84028191; -.
DR   PaxDb; P10635; -.
DR   PeptideAtlas; P10635; -.
DR   PRIDE; P10635; -.
DR   Ensembl; ENST00000359033; ENSP00000351927; ENSG00000100197. [P10635-2]
DR   Ensembl; ENST00000360608; ENSP00000353820; ENSG00000100197. [P10635-1]
DR   Ensembl; ENST00000612990; ENSP00000483677; ENSG00000275211.
DR   GeneID; 1565; -.
DR   KEGG; hsa:1565; -.
DR   UCSC; uc003bce.4; human. [P10635-1]
DR   CTD; 1565; -.
DR   DisGeNET; 1565; -.
DR   GeneCards; CYP2D6; -.
DR   HGNC; HGNC:2625; CYP2D6.
DR   HPA; HPA045223; -.
DR   MalaCards; CYP2D6; -.
DR   MIM; 124030; gene.
DR   MIM; 608902; phenotype.
DR   neXtProt; NX_P10635; -.
DR   OpenTargets; ENSG00000100197; -.
DR   Orphanet; 413667; Antidepressant or antipsychotics toxicity or dose selection.
DR   Orphanet; 240867; Codeine toxicity.
DR   Orphanet; 240947; Resistance to tamoxifene.
DR   PharmGKB; PA128; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118775; -.
DR   HOVERGEN; HBG015789; -.
DR   InParanoid; P10635; -.
DR   KO; K17712; -.
DR   OMA; DEANWEK; -.
DR   OrthoDB; EOG091G0BT8; -.
DR   PhylomeDB; P10635; -.
DR   TreeFam; TF352043; -.
DR   BRENDA; 1.14.14.1; 2681.
DR   BRENDA; 1.14.99.38; 2681.
DR   Reactome; R-HSA-211935; Fatty acids.
DR   Reactome; R-HSA-211958; Miscellaneous substrates.
DR   Reactome; R-HSA-211981; Xenobiotics.
DR   Reactome; R-HSA-211999; CYP2E1 reactions.
DR   SABIO-RK; P10635; -.
DR   EvolutionaryTrace; P10635; -.
DR   GeneWiki; CYP2D6; -.
DR   GenomeRNAi; 1565; -.
DR   PRO; PR:P10635; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100197; -.
DR   CleanEx; HS_CYP2D6; -.
DR   ExpressionAtlas; P10635; baseline and differential.
DR   Genevisible; P10635; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:BHF-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:BHF-UCL.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008144; F:drug binding; IDA:BHF-UCL.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL.
DR   GO; GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; TAS:Reactome.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0009822; P:alkaloid catabolic process; IDA:BHF-UCL.
DR   GO; GO:0009820; P:alkaloid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IBA:GO_Central.
DR   GO; GO:0009804; P:coumarin metabolic process; IDA:BHF-UCL.
DR   GO; GO:0042737; P:drug catabolic process; IDA:BHF-UCL.
DR   GO; GO:0017144; P:drug metabolic process; IDA:BHF-UCL.
DR   GO; GO:0046483; P:heterocycle metabolic process; IDA:BHF-UCL.
DR   GO; GO:0033076; P:isoquinoline alkaloid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0051100; P:negative regulation of binding; IDA:BHF-UCL.
DR   GO; GO:0090350; P:negative regulation of cellular organofluorine metabolic process; IDA:BHF-UCL.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL.
DR   GO; GO:0070989; P:oxidative demethylation; IDA:BHF-UCL.
DR   GO; GO:0008202; P:steroid metabolic process; IMP:BHF-UCL.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:BHF-UCL.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR008069; Cyt_P450_E_grp-I_CYP2D-like.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR01686; EP450ICYP2D.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Endoplasmic reticulum; Heme; Iron; Lipid metabolism; Membrane;
KW   Metal-binding; Microsome; Monooxygenase; Oxidoreductase; Polymorphism;
KW   Reference proteome; Steroid metabolism; Sterol metabolism.
FT   CHAIN         1    497       Cytochrome P450 2D6.
FT                                /FTId=PRO_0000051731.
FT   METAL       443    443       Iron (heme axial ligand).
FT   BINDING     301    301       Substrate. {ECO:0000305}.
FT   VAR_SEQ     118    168       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044486.
FT   VARIANT       5      5       A -> V (in allele CYP2D6*87;
FT                                dbSNP:rs773790593).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072764.
FT   VARIANT      11     11       V -> M (in allele CYP2D6*35;
FT                                dbSNP:rs769258).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_008366.
FT   VARIANT      25     25       R -> Q (in dbSNP:rs138417770).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072765.
FT   VARIANT      26     26       R -> H (in allele CYP2D6*21 and allele
FT                                CYP2D6*46; dbSNP:rs28371696).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:15768052,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_008367.
FT   VARIANT      28     28       R -> C (in allele CYP2D6*22;
FT                                dbSNP:rs138100349).
FT                                /FTId=VAR_008368.
FT   VARIANT      34     34       P -> S (in allele CYP2D6*10 and allele
FT                                CYP2D6*14; poor debrisquone metabolism;
FT                                dbSNP:rs1065852).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:25469868,
FT                                ECO:0000269|PubMed:8287064}.
FT                                /FTId=VAR_008336.
FT   VARIANT      42     42       G -> R (in allele CYP2D6*12; impaired
FT                                metabolism of sparteine;
FT                                dbSNP:rs5030862).
FT                                {ECO:0000269|PubMed:8655150}.
FT                                /FTId=VAR_001256.
FT   VARIANT      85     85       A -> V (in allele CYP2D6*23;
FT                                dbSNP:rs267608310).
FT                                /FTId=VAR_008369.
FT   VARIANT      91     91       L -> M (in dbSNP:rs28371703).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024720.
FT   VARIANT      94     94       H -> R (in dbSNP:rs28371704).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024721.
FT   VARIANT     104    104       V -> A (in allele CYP2D6*88;
FT                                dbSNP:rs76187628).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072766.
FT   VARIANT     107    107       T -> I (in allele CYP2D6*17; poor
FT                                debrisquone metabolism;
FT                                dbSNP:rs28371706).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:8971426}.
FT                                /FTId=VAR_008337.
FT   VARIANT     120    120       F -> I (in dbSNP:rs1135822).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024722.
FT   VARIANT     142    142       L -> S (in allele CYP2D6*89; >90%
FT                                decrease of monooxygenase activity
FT                                towards dextromethorphan and bufuralol;
FT                                dbSNP:rs375135093).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072767.
FT   VARIANT     147    147       K -> R (in allele CYP2D6*90;
FT                                dbSNP:rs569229126).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072768.
FT   VARIANT     155    155       E -> K (in allele CYP2D6*45A, allele
FT                                CYP2D6*45B and allele CYP2D6*46;
FT                                dbSNP:rs28371710).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:15768052}.
FT                                /FTId=VAR_024723.
FT   VARIANT     161    161       C -> S (in allele CYP2D6*91).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072769.
FT   VARIANT     164    164       F -> L. {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072770.
FT   VARIANT     169    169       G -> R (in allele CYP2D6*14; poor
FT                                debrisquone metabolism; dbSNP:rs5030865).
FT                                {ECO:0000269|PubMed:10064570}.
FT                                /FTId=VAR_008338.
FT   VARIANT     212    212       G -> E (in allele CYP2D6*6B and allele
FT                                CYP2D6*6C; dbSNP:rs5030866).
FT                                {ECO:0000269|PubMed:7868129}.
FT                                /FTId=VAR_008339.
FT   VARIANT     215    215       E -> K (>90% decrease of monooxygenase
FT                                activity towards dextromethorphan and
FT                                bufuralol; dbSNP:rs567606867).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072771.
FT   VARIANT     219    219       F -> S (in dbSNP:rs371793722).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072772.
FT   VARIANT     231    231       L -> P (in dbSNP:rs17002853).
FT                                /FTId=VAR_045679.
FT   VARIANT     237    237       A -> S (in allele CYP2D6*33;
FT                                dbSNP:rs28371717).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_008370.
FT   VARIANT     249    249       T -> P (in allele CYP2D6*93; >90%
FT                                decrease of monooxygenase activity
FT                                towards dextromethorphan and bufuralol).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072773.
FT   VARIANT     281    281       Missing (in allele CYP2D6*9).
FT                                {ECO:0000269|PubMed:1844820}.
FT                                /FTId=VAR_008347.
FT   VARIANT     296    296       R -> C (in allele CYP2D6*2, allele
FT                                CYP2D6*12, allele CYP2D6*14, allele
FT                                CYP2D6*17, allele CYP2D6*45A, allele
FT                                CYP2D6*45B and allele CYP2D6*46; slightly
FT                                decrease of monooxygenase activity
FT                                towards bufuralol; dbSNP:rs16947).
FT                                {ECO:0000269|PubMed:10591208,
FT                                ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:15768052,
FT                                ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_008340.
FT   VARIANT     297    297       I -> L (in allele CYP2D6*24).
FT                                /FTId=VAR_008371.
FT   VARIANT     300    300       A -> G (in dbSNP:rs1058170).
FT                                /FTId=VAR_045680.
FT   VARIANT     311    311       S -> L (in dbSNP:rs1800754).
FT                                /FTId=VAR_014633.
FT   VARIANT     324    324       H -> P (in allele CYP2D6*7; loss of
FT                                activity; dbSNP:rs5030867).
FT                                {ECO:0000269|PubMed:7845481}.
FT                                /FTId=VAR_008348.
FT   VARIANT     327    327       V -> M. {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072774.
FT   VARIANT     329    329       R -> L (in dbSNP:rs3915951).
FT                                /FTId=VAR_059150.
FT   VARIANT     336    336       D -> N (in dbSNP:rs745746329).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072775.
FT   VARIANT     337    337       D -> G (in allele CYP2D6*94;
FT                                dbSNP:rs748712690).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072776.
FT   VARIANT     342    342       V -> M (in dbSNP:rs750996195).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072777.
FT   VARIANT     343    343       R -> G (in allele CYP2D6*25;
FT                                dbSNP:rs267608295).
FT                                /FTId=VAR_008372.
FT   VARIANT     344    344       R -> Q (in dbSNP:rs76088846).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072778.
FT   VARIANT     365    365       R -> H (in dbSNP:rs1058172).
FT                                /FTId=VAR_045681.
FT   VARIANT     369    369       I -> T (in allele CYP2D6*26).
FT                                /FTId=VAR_008373.
FT   VARIANT     373    373       G -> S (in dbSNP:rs2856959).
FT                                /FTId=VAR_059151.
FT   VARIANT     410    410       E -> K (in allele CYP2D6*27;
FT                                dbSNP:rs769157652).
FT                                /FTId=VAR_008374.
FT   VARIANT     418    418       E -> K (in dbSNP:rs149157808).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024724.
FT   VARIANT     440    440       R -> C (>90% decrease of monooxygenase
FT                                activity towards dextromethorphan and
FT                                bufuralol; dbSNP:rs777560972).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072779.
FT   VARIANT     457    457       F -> L (in allele CYP2D6*97).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072780.
FT   VARIANT     463    463       H -> D (in allele CYP2D6*98).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072781.
FT   VARIANT     469    469       P -> A (in dbSNP:rs1135833).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024725.
FT   VARIANT     478    478       H -> Y (in dbSNP:rs28371735).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024726.
FT   VARIANT     486    486       S -> T (in allele CYP2D6*2, allele
FT                                CYP2D6*10, allele CYP2D6*12, allele
FT                                CYP2D6*14, allele CYP2D6*17, allele
FT                                CYP2D6*45A, allele CYP2D6*45B and allele
FT                                CYP2D6*46; impaired metabolism of
FT                                sparteine; dbSNP:rs1135840).
FT                                {ECO:0000269|PubMed:10591208,
FT                                ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:15768052,
FT                                ECO:0000269|PubMed:25469868,
FT                                ECO:0000269|PubMed:8287064}.
FT                                /FTId=VAR_008341.
FT   VARIANT     497    497       R -> C (in dbSNP:rs370580423).
FT                                {ECO:0000269|PubMed:25469868}.
FT                                /FTId=VAR_072782.
FT   CONFLICT    374    374       V -> M (in Ref. 1; AAA52153 and 2;
FT                                CAA30807). {ECO:0000305}.
FT   TURN         41     43       {ECO:0000244|PDB:3TBG}.
FT   HELIX        46     48       {ECO:0000244|PDB:3TBG}.
FT   STRAND       51     53       {ECO:0000244|PDB:5TFT}.
FT   HELIX        54     65       {ECO:0000244|PDB:3TBG}.
FT   STRAND       67     73       {ECO:0000244|PDB:3TBG}.
FT   STRAND       76     81       {ECO:0000244|PDB:3TBG}.
FT   HELIX        83     91       {ECO:0000244|PDB:3TBG}.
FT   TURN         92     94       {ECO:0000244|PDB:3TBG}.
FT   HELIX        95     97       {ECO:0000244|PDB:3TBG}.
FT   HELIX       105    110       {ECO:0000244|PDB:3TBG}.
FT   STRAND      119    121       {ECO:0000244|PDB:4WNU}.
FT   HELIX       126    141       {ECO:0000244|PDB:3TBG}.
FT   STRAND      145    147       {ECO:0000244|PDB:4WNU}.
FT   HELIX       148    165       {ECO:0000244|PDB:3TBG}.
FT   TURN        166    169       {ECO:0000244|PDB:3TBG}.
FT   HELIX       175    191       {ECO:0000244|PDB:3TBG}.
FT   HELIX       200    214       {ECO:0000244|PDB:3TBG}.
FT   HELIX       219    226       {ECO:0000244|PDB:3TBG}.
FT   HELIX       228    232       {ECO:0000244|PDB:3TBG}.
FT   HELIX       234    240       {ECO:0000244|PDB:3TBG}.
FT   HELIX       242    261       {ECO:0000244|PDB:3TBG}.
FT   HELIX       271    281       {ECO:0000244|PDB:3TBG}.
FT   TURN        282    284       {ECO:0000244|PDB:3TBG}.
FT   HELIX       292    323       {ECO:0000244|PDB:3TBG}.
FT   HELIX       325    338       {ECO:0000244|PDB:3TBG}.
FT   STRAND      341    343       {ECO:0000244|PDB:3TBG}.
FT   HELIX       347    350       {ECO:0000244|PDB:3TBG}.
FT   HELIX       354    367       {ECO:0000244|PDB:3TBG}.
FT   STRAND      370    372       {ECO:0000244|PDB:3QM4}.
FT   STRAND      382    384       {ECO:0000244|PDB:3TBG}.
FT   STRAND      387    389       {ECO:0000244|PDB:3TBG}.
FT   STRAND      394    397       {ECO:0000244|PDB:3TBG}.
FT   HELIX       399    403       {ECO:0000244|PDB:3TBG}.
FT   TURN        406    408       {ECO:0000244|PDB:3TBG}.
FT   STRAND      409    411       {ECO:0000244|PDB:3TBG}.
FT   HELIX       417    420       {ECO:0000244|PDB:3TBG}.
FT   HELIX       439    441       {ECO:0000244|PDB:4WNV}.
FT   HELIX       446    463       {ECO:0000244|PDB:3TBG}.
FT   STRAND      464    467       {ECO:0000244|PDB:3TBG}.
FT   STRAND      470    472       {ECO:0000244|PDB:4WNW}.
FT   STRAND      479    487       {ECO:0000244|PDB:3TBG}.
FT   STRAND      492    496       {ECO:0000244|PDB:3TBG}.
SQ   SEQUENCE   497 AA;  55769 MW;  542B1D505DF3CDAC CRC64;
     MGLEALVPLA VIVAIFLLLV DLMHRRQRWA ARYPPGPLPL PGLGNLLHVD FQNTPYCFDQ
     LRRRFGDVFS LQLAWTPVVV LNGLAAVREA LVTHGEDTAD RPPVPITQIL GFGPRSQGVF
     LARYGPAWRE QRRFSVSTLR NLGLGKKSLE QWVTEEAACL CAAFANHSGR PFRPNGLLDK
     AVSNVIASLT CGRRFEYDDP RFLRLLDLAQ EGLKEESGFL REVLNAVPVL LHIPALAGKV
     LRFQKAFLTQ LDELLTEHRM TWDPAQPPRD LTEAFLAEME KAKGNPESSF NDENLRIVVA
     DLFSAGMVTT STTLAWGLLL MILHPDVQRR VQQEIDDVIG QVRRPEMGDQ AHMPYTTAVI
     HEVQRFGDIV PLGVTHMTSR DIEVQGFRIP KGTTLITNLS SVLKDEAVWE KPFRFHPEHF
     LDAQGHFVKP EAFLPFSAGR RACLGEPLAR MELFLFFTSL LQHFSFSVPT GQPRPSHHGV
     FAFLVSPSPY ELCAVPR
//
